This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/kegg-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03619/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03619
rdf:type
n3:Drug
n3:description
A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB03619 n14:DB03619
dcterms:title
Deoxycholic Acid
adms:identifier
n8:46506360 n9:28834 n10:DHO n11:7000965 n12:DB03619 n13:C04483
n3:synthesisReference
Filiberto Zadini, Giorgio Zadini, "Deoxycholic acid liposome-based dermatological topical preparation." U.S. Patent US20060222695, issued October 05, 2006.
n3:IUPAC-Name
n4:271B5978-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B597E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B597D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B597A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B597B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B597C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5976-363D-11E5-9242-09173F13E4C5 n4:271B598E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5977-363D-11E5-9242-09173F13E4C5 n4:271B5974-363D-11E5-9242-09173F13E4C5 n4:271B5990-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5975-363D-11E5-9242-09173F13E4C5 n4:271B5991-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5984-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5985-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B597F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5980-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5982-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5981-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5983-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
83-44-3
n3:Bioavailability
n4:271B598A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B598C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B598D-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B598F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5989-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5988-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B598B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5979-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5986-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5987-363D-11E5-9242-09173F13E4C5